Skip to main content

Peer Review reports

From: HLA-E restricted cytomegalovirus UL40 peptide polymorphism may represent a risk factor following congenital infection

Original Submission
5 Jan 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
21 Feb 2022 Reviewed Reviewer Report - José Manuel Nunes
25 Mar 2022 Reviewed Reviewer Report
8 Apr 2022 Author responded Author comments - David Tarragó
Resubmission - Version 4
8 Apr 2022 Submitted Manuscript version 4
12 Apr 2022 Author responded Author comments - David Tarragó
Resubmission - Version 5
12 Apr 2022 Submitted Manuscript version 5
18 Apr 2022 Author responded Author comments - David Tarragó
Resubmission - Version 6
18 Apr 2022 Submitted Manuscript version 6
5 May 2022 Reviewed Reviewer Report
11 May 2022 Reviewed Reviewer Report - José Manuel Nunes
18 May 2022 Author responded Author comments - David Tarragó
Resubmission - Version 7
18 May 2022 Submitted Manuscript version 7
24 May 2022 Reviewed Reviewer Report
9 Jun 2022 Reviewed Reviewer Report - José Manuel Nunes
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
10 Jun 2022 Editorially accepted
20 Jun 2022 Article published 10.1186/s12864-022-08689-0

You can find further information about peer review here.

Back to article page